Changeflow GovPing Pharma & Healthcare Prophylactic Anti-epileptic Regimen in Traumati...
Routine Notice Added Final

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered an observational clinical trial (NCT07535736) evaluating the effectiveness and safety of anti-epileptic drugs in preventing early and late post-traumatic seizures among patients with traumatic brain injury. The study will assess antiepileptic efficacy and safety outcomes in this patient population.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This ClinicalTrials.gov registration documents a new observational study examining whether anti-epileptic drugs can prevent seizures following traumatic brain injury. The trial will observe patients to evaluate both effectiveness in seizure prevention and drug safety profiles.

For clinical investigators and healthcare providers, this registration signals an active research focus on improving post-TBI neurological outcomes. Sponsors conducting similar research may find this trial relevant for competitive intelligence or potential collaboration in the neurological injury space.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

Observational NCT07535736 Kind: OBSERVATIONAL Apr 17, 2026

Abstract

To evaluate the effectiveness and safety of anti-epileptic drugs in the prevention of early and late post-traumatic seizures among patients with trauma brain injury

Conditions: Antiepileptic Efficacy and Safety, Brain Injuries

Interventions: Anti-Epileptic

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 17th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07535736
Docket
NCT07535736

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing 6211 Healthcare Providers
Activity scope
Clinical trial registration Drug efficacy study Patient safety research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!